bonaventuregaspesie.com

PDF) Evaluation préclinique d'une nouvelle stratégie de radiosensibilisation pharmacologique : l'inhibition des histones désacétylases

5 (344) · € 21.99 · En Stock

Les resultats insuffisants de la radiochimiotherapie conventionnelle dans les cancers bronchiques non a petites cellules (CBNPC) ont motive l’evaluation d’une nouvelle strategie de modulation pharmacologique de la radiosensibilite tumorale basee sur

IJMS, Free Full-Text

Discovery of Selective Histone Deacetylase 1 and 2 Inhibitors: Screening of a Focused Library Constructed by Click Chemistry, Kinetic Binding Analysis, and Biological Evaluation

Frontiers Evaluation of Histone Deacetylase Inhibitors as Radiosensitizers for Proton and Light Ion Radiotherapy

Targeting histone deacetylases for cancer therapy: Trends and challenges - ScienceDirect

PDF) Histone Deacetylase Inhibitors: Advancing Therapeutic Strategies in Hematological and Solid Malignancies

IJMS, Free Full-Text

Targeting histone deacetylases for cancer therapy: Trends and challenges - ScienceDirect

Full article: Design, synthesis and biological evaluation of novel histone deacetylase (HDAC) inhibitors derived from β-elemene scaffold

Frontiers Phase Ib Study of the Histone Deacetylase 6 Inhibitor Citarinostat in Combination With Paclitaxel in Patients With Advanced Solid Tumors

Targeting histone deacetylases for cancer therapy: Trends and challenges - ScienceDirect

Therapeutic application of histone deacetylase inhibitors for central nervous system disorders

IJMS, Free Full-Text

Frontiers Evaluation of Histone Deacetylase Inhibitors as Radiosensitizers for Proton and Light Ion Radiotherapy